PITTSBURGH--(BUSINESS WIRE)--Helomics Corporation, a privately held comprehensive personalized healthcare company that develops innovative next generation diagnostics for the oncology field, announced today that the company will attend the 2016 Biotechnology Innovation Organization (BIO) International Convention being held June 6 - 9, 2016, in San Francisco. Helomics will represent Pennsylvania’s life sciences industry at the gathering of 15,000 global biotechnology and pharma leaders.
